Anika Therapeutics Inc.

ANIK | NASDAQ

Price Alert Chart Builder DCF Calculator

$20.95

+$0.25 (+1.21%)

Sep 22, 2026, 12:25 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $277.03M

Enterprise Value $261.93M

Beta 0.20

Average Volume 96.9K

Shares Outstanding (Diluted) 13.43M

Shares Change YoY -6.5%

Institutional Ownership 91.34%

Exchange NASDAQ

ISIN US0352551081

Price Performance

Price Change 1M -7.0%

Price Change 3M 41.9%

Price Change 6M 42.2%

Price Change YTD 121.4%

Price Change 1Y 121.6%

Price Change 3Y 13.1%

Price Change 5Y -47.8%

1M CAGR (ann.) -3.4%

1Y CAGR (ann.) 131.5%

5Y CAGR (ann.) -12.2%

All-Time CAGR 2.5%

Valuation

PE Ratio -76.67

Forward PE 20.34

PEG Ratio -0.27

Forward PEG 8.06

PS Ratio 2.30

Forward PS 2.20

PB Ratio 2.02

P/FCF Ratio 492.93

P/Adj. FCF Ratio -22.01

P/OCF Ratio 46.00

EV/Sales 2.17

EV/EBIT -89.92

EV/EBITDA 96.40

EV/FCF 466.07

Earnings Yield -1.3%

FCF Yield 0.2%

Adj. FCF Yield -4.5%

Financial Health

Net Cash $15.1M

Total Debt $23.32M

Cash & Short-Term Investments $38.41M

Total Assets $183.47M

Current Ratio 4.48

Quick Ratio 3.19

Debt / Equity Ratio 0.17

Debt / EBITDA 8.58

Debt / FCF 41.49

OCF / Debt 0.26

Interest Coverage 0.00

Altman Z-Score 5.16

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 62.2%

Operating Profit Margin -4.2%

EBITDA Margin 2.3%

Net Profit Margin -3.1%

FCF Margin 0.5%

Adj. FCF Margin -10.4%

SBC / Revenue 10.9%

SBC Impact (per share) -2339.3%

Returns

Return on Assets -2.1%

Return on Equity -2.7%

Return on Invested Capital -3.2%

Return on Capital Employed -3.2%

Return on Tangible Assets -2.2%

Historical Growth (CAGR)

Revenue CAGR 3Y -9.4%

Revenue CAGR 5Y -2.5%

Revenue CAGR 10Y 1.6%

EPS CAGR 3Y 75.9%

EPS CAGR 5Y -7.0%

EPS CAGR 10Y -97.5%

FCF CAGR 3Y -152.9%

FCF CAGR 5Y -39.4%

FCF CAGR 10Y -26.9%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 7

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y 7.3%

Earnings Date Nov 3, 2026

EPS Estimate (next Q) $0.17

EPS Growth Est (next Q) 325.0%

Revenue Est (next Q) $29.44M

Revenue Growth Est (next Q) 5.8%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $21

Price Target Upside 1.4%

Cash Flow

Operating Cash Flow $5.98M

Free Cash Flow $562K

Adj. Free Cash Flow $-12.59M

FCF Per Share $0.04

OCF Per Share $0.45

OCF/S Ratio 5.0%

Income Statement

Revenue $120.65M

Gross Profit $75M

Operating Income $-5.12M

EBITDA $2.72M

Net Income $-3.78M

EPS (Diluted) -$0.27

Revenue / Employee $513.42K

Profit / Employee $-16.1K

Employees 235